首页 > 市场调查报告书 > 製药

疫苗动物用医药

北美家禽疫苗市场预测至 2031 年 - 区域分析 - 按类型、技术、剂型、疾病、给药途径和最终用户

市场调查报告书

商品编码

1597053

北美家禽疫苗市场预测至 2031 年 - 区域分析 - 按类型、技术、剂型、疾病、给药途径和最终用户

North America Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

出版日期: 2024年10月17日 | 出版商:

The Insight Partners | 英文 117 Pages | 订单完成后即时交付

价格

简介目录图表

2023年北美家禽疫苗市值为7.0204亿美元，预计到2031年将达到13.2726亿美元；预计2023年至2031年复合年增长率为8.3%。

家禽疾病盛行率上升推动北美家禽疫苗市场

家禽生产透过鸡蛋和肉类生产不同类型的动物蛋白质。随着家禽产量的增加，人们很容易感染「禽病」等几种人畜共通传染病，这可能会导致巨大的经济损失，特别是在发展中国家。例如，鸡更容易受到细菌、病毒、寄生虫和真菌感染。这些病毒爆发可引起新城疫、禽流感、传染性法氏囊病和其他家禽动物的其他疾病。

下表提供了 2022 年加拿大各地哺乳动物禽流感疫情的情况。

哺乳动物感染禽流感病例

国家

家禽疾病

疾病爆发 (2022)

加拿大

40

加拿大

H5N5

2

资料来源：世界动物卫生组织 2023

家禽疾病是雏鸡死亡的主要原因，也导致鸡隻的牲畜生产力下降。由于农民传播人畜共通传染病，给哺乳动物带来严重的健康风险，他们在全球范围内面临巨大的经济损失。例如，家禽球虫病是全球最常见的疾病之一；它导致与死亡率、体重减轻以及与预防和治疗控制相关的额外费用相关的巨大损失。根据帝斯曼网站的数据，全球范围内的鸡和禽类球虫病导致农民每年面临 30 亿美元的经济损失。新城疫也被认为是一种经济代价高昂的疾病，对出口家禽产品的发展中国家的农民造成巨大的生产损失。

因此，家禽疾病流行率的上升造成巨大的经济损失，增加了家禽疫苗接种的需求，从而带动了市场。

北美洲家禽疫苗市场概况

北美占据家禽疫苗市场的主要份额。在北美区域市场中，美国占据最大份额，因为该国拥有顶级公司和完善的疫苗接种服务中心。上述事实是预测期内影响该地区市场成长的关键因素之一。

北美家禽疫苗市场收入及 2031 年预测（百万美元）

北美家禽疫苗市场细分

北美家禽疫苗市场按类型、技术、剂型、疾病、给药途径、最终用户和国家分类。

根据类型，北美家禽疫苗市场分为肉鸡和蛋鸡。 2023 年，肉鸡细分市场将占据更大的市场份额。

从技术上来看，北美家禽疫苗市场分为减毒活疫苗、灭活疫苗和重组疫苗。减毒活疫苗细分市场在 2023 年占据最大的市场。

以剂型划分，北美家禽疫苗市场分为液体疫苗、冷冻干燥疫苗和粉状/粉状疫苗。 2023 年，液体疫苗领域占据最大的市场。

根据疾病，北美家禽疫苗市场分为禽流感、传染性支气管炎、马立克氏症、禽沙门氏菌病、传染性法氏囊病（IBD）、新城疫等。 2023 年，禽流感细分市场占最大市场。

从给药途径来看，北美家禽疫苗市场分为饮用水（D/W）、肌肉（I/M）、皮下（I/S）等。 2023 年，饮用水 (D/W) 领域占据最大的市场份额。

根据最终用户，北美家禽疫苗市场分为家禽养殖场和孵化场、兽医院以及家禽疫苗接种中心和诊所。 2023 年，家禽养殖场和孵化场领域占据最大的市场份额。

按国家/地区划分，北美家禽疫苗市场分为美国、加拿大和墨西哥。 2023年，美国在北美家禽疫苗市场份额中占据主导地位。

Starkey Laboratories Inc.、Audina Hearing Instruments Inc.、Sebotek Hearing Systems LLC、Earlens Corp、GN Store Nord AS、Cochlear Ltd、WS Audiology AS、Sonova Holding AG、Sonic Innovations Inc 和 Amplifon Hearing Health Care Corp. 是一些领先的公司在北美家禽疫苗市场营运的公司。

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

North America Poultry Vaccines Market Overview

North America accounts major share for poultry vaccines market. Among the North America regional market, US accounts maximum share due to presence of top companies in the country and well-established centers providing vaccination services. Such aforementioned facts are one of the key factors that influence market growth in the region for the forecast period.

North America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

North America Poultry Vaccines Market Segmentation

The North America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the North America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the North America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the North America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the North America poultry vaccines market is segmented into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the North America poultry vaccines market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the North America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the North America poultry vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry vaccines market share in 2023.

Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America poultry vaccines market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. North America Poultry Vaccines Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Poultry Diseases
- 4.1.2 Growing Poultry Industry
4.2 Market Restraints
- 4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
- 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
- 4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:

5. North America Poultry Vaccines Market Analysis

5.1 Poultry Vaccines Market Revenue (US$ Million), 2023-2031

6. North America Poultry Vaccines Market Analysis - by Type

6.1 Overview
6.2 Broiler
- 6.2.1 Overview
- 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
- 6.3.1 Overview
- 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Poultry Vaccines Market Analysis - by Technology

7.1 Overview
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
- 7.4.1 Overview
- 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Poultry Vaccines Market Analysis - by Dosage Form

8.1 Overview
8.2 Liquid Vaccines
- 8.2.1 Overview
- 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
- 8.3.1 Overview
- 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
- 8.4.1 Overview
- 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Poultry Vaccines Market Analysis - by Disease

9.1 Overview
9.2 Avian Influenza
- 9.2.1 Overview
- 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Salmonellosis
- 9.3.1 Overview
- 9.3.2 Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Marek's Disease
- 9.4.1 Overview
- 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
- 9.5.1 Overview
- 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
- 9.6.1 Overview
- 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
- 9.7.1 Overview
- 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Poultry Vaccines Market Analysis - by Route of Administration

10.1 Overview
10.2 Drinking Water (D/W)
- 10.2.1 Overview
- 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
- 10.3.1 Overview
- 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
- 10.4.1 Overview
- 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Poultry Vaccines Market Analysis - by End User

11.1 Overview
11.2 Poultry Farms
- 11.2.1 Overview
- 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
- 11.3.1 Overview
- 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers and Clinics
- 11.4.1 Overview
- 11.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. North America Poultry Vaccines Market - Country Analysis

12.1 North America Market Overview
- 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 12.1.1.1 United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 United States: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.1.3 United States: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.1.5 United States: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
    - 12.1.1.1.7 United States: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.2 Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 Canada: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
    - 12.1.1.2.7 Canada: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.3 Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
    - 12.1.1.3.7 Mexico: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
- 13.3.1 Overview
13.1 Inorganic Developments
- 13.1.1 Overview

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Zoetis Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Phibro Animal Health Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Elanco Animal Health Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Ceva
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Vaccinova AB
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Poultry Vaccines Market Segmentation
Table 2. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 3. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
Table 4. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 5. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
Table 6. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
Table 7. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 8. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 9. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
Table 10. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 11. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
Table 12. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
Table 13. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 14. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
Table 15. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
Table 16. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
Table 17. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
Table 18. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route Of Administration
Table 19. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Vaccine Adjuvants Market

List Of Figures

Figure 1. North America Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2023-2031
Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 33. North America: Poultry Vaccines Market by Key Countries - Revenue (2023) US$ Million
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. United States: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
Figure 36. Canada: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
Figure 37. Mexico: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
Figure 38. Growth Strategies in the Poultry Vaccines Market